Zdrowie i gospodarka · 23/01/2018

FDA Requests Public Comment on Proposed Collection of Information for Blood and Blood Components Regulation

The Food and Drug Administration (FDA) is seeking public input on proposed regulations for blood and blood components, including current good manufacturing practices and requirements for donation testing and notification, as part of its efforts to modernize its regulatory framework.